Comparison

Human RelA (p65) NF-kappa B (NF-kB, Nuclear Factor-kappa B) ELISA Assay Kit

Manufacturer Fivephoton
Category
Type Elisa-Kit
Specific against other
Amount 1 Kit, 96T
Item no. NFKB-ELISA(h)
Targets NFKB1
eClass 6.1 32160605
eClass 9.0 32160605
Available
Highlights
Detects total human p65(RELA)
Affinity purified polyclonal capture antibody, with polyclonal HRP-conjugated detection antibody
Standard Peptide Concentration: 2250 pg/ml
Assay Range: 100 - 2000 pg/ml
HRP-Colorimetric detection at 450nM
Strip plate format
Rapid assay: 1 hr total incubation time at 37C (i.e. with plate and HRP-detection Ab).
Nuclear-Cytoplasm Isolation Kit offered as an option to separately quantitate nuclear and cytoplasmic p65 as a method to estimate levels of NF-kappa B activation
Separate p65 ELISA kits are offered for human, mouse and rat
Background
The RelA p65 NF-kB (NF-kappa B, NF-{kappa}B) ELISA kit employs the sandwich ELISA(96T) format to quantitate NF-kB p65 protein levels. The 96-well strip plate is coated with an affinity purified polyclonal capture antibody selective to the RelA (p65) subunit of NF-kB. After addition of sample, incubation and wash, a second polyclonal anti-RelA (p65) HRP-conjugated antibody is added to each well. Color reagents are added to generate a colorimetric reaction, which corresponds to the concentration of RelA (p65) in the sample.

A Nuclear-Cytoplasmic fractionation kit is offered to partition cytoplasmic and nuclear p65. p65(RelA) in the nuclear and cytoplosmic fractions can be directly measured with this kit to provide an estimate of NF-kappa B activation by calculation of the nuclear p65 relative to cytoplasmic p65 concentration ratio.
References
Baudy, A.R. et al. (2009) A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases. Int Immunopharmacol 9 (10), 1209-1214.

Dann, S.G. et al. (2004) Chromatin immunoprecipitation assay on the rainbow trout opsin proximal promoters illustrates binding of NF-kappaB and c-jun to the SWS1 promoter in the retina. Exp Eye Res 78 (5), 1015-1024.

Hassan, N.J. et al. (2009) Development of an insect-cell-based assay for detection of kinase inhibition using NF-kappaB-inducing kinase as a paradigm. Biochem J 419 (1), 65-73.

Hellweg, C.E. et al. (2003) Generation of stably transfected Mammalian cell lines as fluorescent screening assay for NF-kappaB activation-dependent gene expression. J Biomol Screen 8 (5), 511-521.

Jin, S. et al. (2005) A simplified probe preparation for ELISA-based NF-kappaB activity assay. J Biochem Biophys Methods 65 (1), 20-29.

Kaur, J. et al. (2008) Chemopreventive activity of lantadenes on two-stage carcinogenesis model in Swiss albino mice: AP-1 (c-jun), NFkappaB (p65) and P53 expression by ELISA and immunohistochemical localization. Mol Cell Biochem 314 (1-2), 1-8.

Klinke, D.J., 2nd et al. (2008) Modulating temporal control of NF-kappaB activation: implications for therapeutic and assay selection. Biophys J 94 (11), 4249-4259.

Li, J.L. et al. (2007) An optimized assay for transcription factor NF-kappaB with dsDNA-coupled microplate. Colloids Surf B Biointerfaces 55 (1), 31-37.

Moon, K.Y. et al. (2001) A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal Biochem 292 (1), 17-21.

Noursadeghi, M. et al. (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J Immunol Methods 329 (1-2), 194-200.

Sun, C.S. et al. (2008) Anti-sense morpholino oligonucleotide assay shows critical involvement for NF-kappaB activation in the production of Wnt-1 protein by HepG2 cells: oncology implications. J Biomed Sci 15 (5), 633-643.

Tomita, K. et al. (1999) Functional assay of NF-kappaB translocation into nuclei by laser scanning cytometry: inhibitory effect by dexamethasone or theophylline. Naunyn Schmiedebergs Arch Pharmacol 359 (4), 249-255.

Wang, J. et al. (2006) Exonuclease-mediated ELISA-like assay for detecting DNA-binding activity of transcription factors: measurement of activated NF-kappaB. Biotechniques 41 (1), 79-88, 90.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 Kit, 96T
Available: In stock
available

Delivery expected until 5/2/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close